| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |